Early-Line Immunotherapy Challenges Transplant Role in Multiple Myeloma

Hear are the citations extracted from the provided text:

1. NCT06376526.IMMUNOPLANT for Newly Diagnosed Multiple Myeloma (IMMUNOPLANT). Clinicaltrials.gov.Updated August 14, 2025. Accessed January 20, 2026. https://clinicaltrials.gov/study/NCT06376526

2. Antibody Therapy Eradicates Traces of Multiple Myeloma in Preliminary Trial. Miller School of Medicine. Published December 6, 2025. accessed January 20, 2026.https://news.med.miami.edu/ash-2025-immunoplant-phase-2-trial/